VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-5.1%)
Cap. Flow
-$9.35M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Oaktree Specialty Lending
OCSL
$1.22B
| $119K | 0.07% |
6,350
-32,688
| -84% | -$125K |
|
|
BLUE
327
DELISTED
bluebird bio
BLUE
| $117K | 0.06% |
36,799
+652
| +2% | +$2.1K |
|
|
BKCC
328
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $116K | 0.06% |
33,485
-81,983
| -71% | -$283K |
|
329
Arbutus Biopharma
ABUS
$753M
| $113K | 0.06% |
37,197
-14,299
| -28% | -$43.3K |
|
|
SWTX
330
DELISTED
SpringWorks Therapeutics
SWTX
| $111K | 0.06% |
4,314
-1,664
| -28% | -$42.8K |
|
|
ISEE
331
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $110K | 0.06% |
4,539
-1,748
| -28% | -$42.5K |
|
|
PNT
332
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $108K | 0.06% |
14,902
-5,727
| -28% | -$41.6K |
|
333
Krystal Biotech
KRYS
$4.35B
| $105K | 0.06% |
1,306
-498
| -28% | -$39.9K |
|
334
Immunovant
IMVT
$2.91B
| $104K | 0.06% |
6,701
-2,575
| -28% | -$39.9K |
|
335
Kymera Therapeutics
KYMR
$3.1B
| $101K | 0.06% |
3,419
-1,310
| -28% | -$38.8K |
|
336
RAPT Therapeutics
RAPT
$187M
| $101K | 0.06% |
5,503
-2,122
| -28% | -$38.9K |
|
337
Stoke Therapeutics
STOK
$1.08B
| $101K | 0.06% |
12,078
-4,637
| -28% | -$38.6K |
|
|
RXDX
338
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $100K | 0.06% |
936
-353
| -27% | -$37.9K |
|
339
Ventyx Biosciences
VTYX
$184M
| $99.8K | 0.05% |
2,980
-1,145
| -28% | -$38.4K |
|
340
Crinetics Pharmaceuticals
CRNX
$3.26B
| $99.8K | 0.05% |
6,215
-2,383
| -28% | -$38.3K |
|
|
CMPS
341
Compass Pathways
CMPS
$452M
| $99.7K | 0.05% |
10,043
-3,853
| -28% | -$38.3K |
|
342
BioXcel Therapeutics
BTAI
$52.7M
| $98.9K | 0.05% |
5,299
-2,034
| -28% | -$37.9K |
|
343
Xencor
XNCR
$594M
| $98.9K | 0.05% |
3,545
-1,366
| -28% | -$38.1K |
|
344
CureVac
CVAC
$1.21B
| $98.4K | 0.05% |
14,114
-5,421
| -28% | -$37.8K |
|
345
Intellia Therapeutics
NTLA
$1.26B
| $97.3K | 0.05% |
2,610
-1,000
| -28% | -$37.3K |
|
|
PNNT
346
Pennant Park Investment Corp
PNNT
$469M
| $95.8K | 0.05% |
18,143
-37,970
| -68% | -$200K |
|
347
Relay Therapeutics
RLAY
$709M
| $95.3K | 0.05% |
5,786
-2,218
| -28% | -$36.5K |
|
348
Arcellx
ACLX
$3.95B
| $94.5K | 0.05% |
3,068
-1,177
| -28% | -$36.3K |
|
349
Kura Oncology
KURA
$732M
| $94K | 0.05% |
7,685
-2,950
| -28% | -$36.1K |
|
|
KDNY
350
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $93.8K | 0.05% |
4,052
-1,558
| -28% | -$36.1K |
|